Presentation is loading. Please wait.

Presentation is loading. Please wait.

RATIONAL DRUG USE POLICY IN TURKEY Dedeoglu, Burcak Deniz; Celik, Hatice Demet; Akbulat, Akif; Akar, Halil; Kerman, Saim.

Similar presentations


Presentation on theme: "RATIONAL DRUG USE POLICY IN TURKEY Dedeoglu, Burcak Deniz; Celik, Hatice Demet; Akbulat, Akif; Akar, Halil; Kerman, Saim."— Presentation transcript:

1 RATIONAL DRUG USE POLICY IN TURKEY Dedeoglu, Burcak Deniz; Celik, Hatice Demet; Akbulat, Akif; Akar, Halil; Kerman, Saim.

2 RATIONAL DRUG USE POLICY IN TURKEY Burcak Deniz Dedeoglu, Hatice Demet Celik, Akif Akbulat, Halil Akar, Saim Kerman Ministry of Health of Turkey, Turkey Studies were conducted by Ministry of Health and many different associations on the issue about “Rational drug use” in Turkey. Institutional activities regarding this issue has been initiated on 12.10.2010 by the Ministry of Health of TURKEY with the establishment of rational drug use department under the the department of pharmacoeconomics. Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the TURKEY and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use. Based on the data taken from SSI, excluding the primary healthcare services, the number of patients applied to a healthcare service and invoices have been sent to SSI in 2008, 2009 and 2010 were 216.930.000, 247.142.000 and 230.112.000 (for first ten months of 2010) respectively, in Turkey. These numbers were classified as “outpatients”, “inpatients”, “others” and “daily” for months. In monthly distrubition perspective, the applications were higher in summer than winter. Total prescription number for workers, civil servants and green card owners in 2009 and 2010 (for first ten months of 2010) were 327.000.000 and 250.138.000 respectively and total prescription invoice number was 16.000 billion TL and 12.259 billion TL. while the average costs per prescription were 48.95 TL. and 49.01 TL, respectively. The expectation is, the rational drug use policy will reduce the total drug cost and increase the awareness of society and health staff about rational drug use. Abstract

3 Studies were conducted by Ministry of Health and many different associations on the issue about “Rational drug use” in Turkey. Institutional activities regarding this issue has been initiated on 12.10.2010 by the Ministry of Health of Turkey with the establishment of rational drug use department. Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the Turkey and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use. Introduction

4 Evaluation the current situation about healthcare services and drugs by analaysing the data of SSI and IMS Institute for Healthcare Informatics. The number of patients applied to a healthcare services and invoice costs; the number of prescription taken from Pharmacy Prevision System and invoice costs; 2010 drug units and costs according to ATC (Anatomical Therapeutic Chemical) codes were analaysed. Objectives

5 Results 1 Application Number (x1000) Invoice Cost (x1000 TL) Mean Cost IC/AN (TL) 2008210.93013.771.43463.48 2009247.14215.653.14363.34 2010277.63418.488.38666.59 2011 (first 5 months) 134.9699.118.78567.56 Table 1: The number of patients applied to a healthcare service, excluding the primary healthcare services, and invoice costs Ref: SSI Monthly Statistical Bulletin; Publication No:13 P.S.: Data are expanded than the abstract because of the new version of SSI Statistical Bulletin

6 Results 2 Prescription Number (x1000) Invoice Cost (x1000 TL) Mean Cost IC/PN (TL) 2008302.41213.046.55643.14 2009327.00116.005.39248.95 2010306.46114.897.45548.61 2011 (first 5 months) 148.5616.537.44244.01 Table 2: The number of prescription taken from Pharmacy Provision System and invoice costs Ref: SSI Monthly Statistical Bulletin; Publication No:13 P.S.: Data are expanded than the abstract because of the new version of SSI Statistical Bulletin

7 Results 3 Units Year/10 (Absolute) A0 ALIMENTARY T.& METABOLISM226.479.339 R0 RESPIRATORY SYSTEM225.593.377 J0 SYSTEMIC ANTI-INFECTIVES223.775.601 M0 MUSCULO-SKELETAL SYSTEM215.060.221 N0 NERVOUS SYSTEM190.285.791 C0 CARDIOVASCULAR SYSTEM153.493.692 D0 DERMATOLOGICALS85.449.907 B0 BLOOD + B.FORMING ORGANS62.125.768 G0 G.U.SYSTEM & SEX HORMONES54.282.589 S0 SENSORY ORGANS45.532.429 V0 VARIOUS38.377.213 H0 SYSTEMIC HORMONES23.332.437 T0 DIAGNOSTIC AGENTS8.162.516 K0 HOSPITAL SOLUTIONS7.818.533 L0 ANTINEOPLAST+IMMUNOMODUL5.242.349 P0 PARASITOLOGY5.040.567 Table 3: Drug Units in 2010 acording to ATC code Ref: IMS Institute for Healthcare Informatics

8 Results 4 TL Year/10 (Absolute) J0 SYSTEMIC ANTI-INFECTIVES2.215.529.632 A0 ALIMENTARY T.& METABOLISM2.112.972.993 C0 CARDIOVASCULAR SYSTEM1.817.350.371 R0 RESPIRATORY SYSTEM1.670.760.391 N0 NERVOUS SYSTEM1.613.233.082 L0 ANTINEOPLAST+IMMUNOMODUL1.260.034.408 M0 MUSCULO-SKELETAL SYSTEM1.142.104.150 G0 G.U.SYSTEM & SEX HORMONES713.159.010 B0 BLOOD + B.FORMING ORGANS631.879.716 D0 DERMATOLOGICALS510.403.595 V0 VARIOUS333.849.317 S0 SENSORY ORGANS302.511.660 T0 DIAGNOSTIC AGENTS230.520.845 H0 SYSTEMIC HORMONES194.499.452 K0 HOSPITAL SOLUTIONS29.833.434 P0 PARASITOLOGY15.592.092 Table 4: Drug costs in 2010 acording to ATC code Ref: IMS Institute for Healthcare Informatics

9 Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the Turkey and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use. The expectation is, the rational drug use policy will reduce the total drug cost and increase the awareness of society and health staff about rational drug use. Policy Implications & Conclutions


Download ppt "RATIONAL DRUG USE POLICY IN TURKEY Dedeoglu, Burcak Deniz; Celik, Hatice Demet; Akbulat, Akif; Akar, Halil; Kerman, Saim."

Similar presentations


Ads by Google